ʻO ka mālama ʻana i ka maʻi maʻi pancreatic ma muli o ka corona

ʻO ka mālama ʻana i ka maʻi maʻi pancreatic ma muli o ka corona

Ua hana ka poʻe ʻepekema i kahi holomua i ka hoʻomohala ʻana i kahi maʻi maʻi maʻi maʻi ma hope o ka hoʻohana ʻana i ka ʻenehana like i hoʻohana ʻia i ka hoʻomohala ʻana i ka maʻi maʻi Corona, i hana ʻia e Piontech-Pfizer Company. ʻO ke kano i hoʻolālā ʻia no kēlā me kēia maʻi, hiki ke hoʻoulu. ʻo ka ʻōnaehana pale e hoʻouka ai i nā maʻi kanesa.

Ua hui pū nā poʻe loea ma hope o ka hoʻomohala ʻana i ka maʻi Pfizer me nā kauka ma New York City e hoʻomohala i kahi kano no nā maʻi maʻi maʻi pancreatic, e like me ka nūpepa Pelekane, "The Telegraph".

Ua hoʻolaha ʻia nā hopena o ka hoʻokolohua lapaʻau o ka pae I, ka mea mua o kāna ʻano, i kēia hopena pule ma ka hālāwai kūkā makahiki o ka American Society of Clinical Oncology (ASCO) ma Chicago.

Manaʻo ka poʻe ʻepekema e hōʻike ana kēia mau ʻike i kahi lā hou o ka mālama ʻana i nā maʻi maʻi maʻi paʻakikī ʻē aʻe, ʻoiai ʻike pinepine ʻia ka maʻi maʻi pancreatic ma ke ʻano he "keiki poster" o ia mau maʻi maʻi make.

ʻO ke ʻano o ka hana o ke kano

A e pili ana i nā kikoʻī o ka hoʻokolohua, underwent i iwakālua mau mea maʻi me ka pancreatic adenocarcinoma (PDAC), e hōʻike ana ma kahi o 90% o nā hihia āpau o ka maʻi maʻi pancreatic, no ka hoʻokolohua.

Ua ʻoki ʻia kēia mau maʻi no ka wehe ʻana i ka maʻi kanesa, a he 72 mau hola ma hope mai ua hoʻouna ʻia kā lākou mau laʻana maʻi maʻi i BioNTech ma Kelemānia no ka mālama ʻana a me ke kano hoʻokahi, i hāʻawi ʻia i ka mea maʻi.

Ua loaʻa pū i nā maʻi ka immunotherapy e kōkua i ka hoʻonui ʻana i kā lākou pane.

Ma nā kapuaʻi o ka maʻi maʻi Corona

Hoʻohana nā lāʻau lapaʻau hou i ka mRNA, kahi genetic code mai ka ʻōpū, e aʻo i nā ʻāpana o ke kino e hana i kahi protein e hoʻoulu ai i ka pane immune, ka ʻenehana like i hoʻohana ʻia i nā kano Corona i hana ʻia e ka hui Pfizer-BioNTech.

A laila, ʻike ke kino he haole maoli ka maʻi maʻi a hoʻouna ʻo T cell e ʻimi iā lākou a pepehi iā lākou inā hoʻi mai.

nā hopena hoʻohiki

He ʻumikūmāono poʻe maʻi i loaʻa i ka mua o ʻeiwa mau kau o ke kano ʻeiwa mau pule ma hope o ke ʻoki ʻana, a ʻo ka hapalua o kēia mau mea i hoʻopuka i kahi pane kūlohelohe koʻikoʻi.

Eia kekahi, ʻo nā maʻi ʻewalu a pau he maʻi maʻi ʻole i 18 mau mahina, e hōʻike ana e hoʻāla ʻia nā cell T i hoʻāla ʻia e ke kano kano e hoʻōki i ka hoʻi hou ʻana o ka maʻi kanesa.

Eia naʻe, ʻewalu mau mea maʻi i pane ʻole i ke kano, ʻoiai ʻeono mau maʻi i ʻike i ko lākou maʻi maʻi maʻi ma hope o hoʻokahi makahiki, a ke noiʻi nei nā mea noiʻi no ke aha i pane ʻole ai ka hapalua o ka hui.

Ua ʻōlelo ʻo Prof Ozlem Turise, ka mea hoʻokumu a me ka luna lapaʻau o BioNTech, ʻelima wale nō pākēneka o nā mea maʻi me ka maʻi maʻi pancreatic i pane i ka mālama ʻana.

"Ke kūpaʻa nei mākou e hoʻokō i kēia paʻakikī ma ke kūkulu ʻana i kā mākou noiʻi lōʻihi i nā kano maʻi maʻi a me ka hoʻāʻo ʻana e wāwahi i kahi kahua hou i ka mālama ʻana i nā maʻi maʻi paʻakikī," wahi āna.